Valisure
ActiveOverview
Valisure is an independent laboratory and technology company specializing in quality assurance and independent testing of pharmaceutical drugs and consumer products. The company addresses a critical gap in the healthcare supply chain by providing transparent, science-based certification and analysis of product purity and safety. Valisure operates as an accredited testing facility aligned with ISO/IEC 17025:2017 standards, serving enterprise clients including health systems, pharmacies, wholesalers, manufacturers, and government agencies.
History
Founded in 2015 by Adam Clark-Joseph and David Light, Valisure began as an innovative pharmacy that tested drugs before dispensing them. The company gained prominence in 2019 when it discovered N-Nitrosodimethylamine in Zantac and generic equivalents, and in 2021 when it identified high benzene levels in Johnson & Johnson sunscreen products. In 2021, Valisure divested its pharmacy business to focus on enterprise testing and quality assurance services. Chip Phillips became CEO in February 2024, succeeding David Light, with the company securing venture funding from AlleyCorp and Connecticut Innovations.
Product Lines
| Product Line | Positioning | Price Range |
|---|---|---|
| Independent Product Certification | Third-party quality verification for pharmaceutical and consumer products | Custom enterprise pricing |
| Analytical Testing Services | Chemical analysis and purity testing for regulated products | Custom enterprise pricing |
| Vendor Validation | Supplier and manufacturer quality assessment | Custom enterprise pricing |
| Consulting Services | Product lifecycle quality guidance and standards compliance | Custom enterprise pricing |
| Market Analysis & Reporting | Competitive product testing and transparency reports | Custom enterprise pricing |
Manufacturing
Valisure operates as an independent laboratory rather than a manufacturing company. The company conducts all testing and analysis in-house at its accredited facility in New Haven, Connecticut, using rigorous analytical chemistry protocols. Testing is performed for third-party clients across the pharmaceutical and consumer product industries.
Notable Products
- Zantac Contamination Analysis (2019) - Discovered N-Nitrosodimethylamine carcinogen in Zantac and generic equivalents, leading to widespread recalls
- Johnson & Johnson Sunscreen Benzene Detection (2021) - Identified high benzene levels in J&J sun tan lotions, prompting product recalls
- Acetaminophen Dissolution Study - Published research in Journal of Therapeutic Innovation & Regulatory Science highlighting quality discrepancies among common acetaminophen products
- Enterprise Quality Assurance Platform - Integrated analytical chemistry testing service for large-scale pharmaceutical and consumer product quality verification
Reputation
Valisure is recognized as a credible independent testing authority that has successfully identified significant quality and safety issues in major consumer and pharmaceutical products. The company is respected for its rigorous scientific methodology and transparency advocacy, earning recognition including Pre-Revenue Venture of the Year at the Connecticut Entrepreneur Awards. Clients include Kaiser Permanente and the United States Armed Forces, reflecting institutional trust. The company addresses a genuine market need for independent quality verification, though its impact remains limited by the voluntary nature of third-party testing in many sectors.